Lipid Nanoparticles for the Posterior Eye Segment

Area of Science:

• Ophthalmology and Pharmaceutical Sciences
• Nanotechnology in Drug Delivery

Background:

• The posterior ocular segment presents unique challenges for drug delivery due to anatomical barriers.
• Diseases affecting the posterior eye segment require effective therapeutic strategies.

Purpose of the Study:

• To review the application of lipid nanoparticles for posterior ocular segment drug delivery.
• To summarize eye anatomy, relevant diseases, and lipid nanoparticle characteristics.

Main Methods:

• Review of literature on lipid nanoparticles (Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, Lipid Drug Conjugates).
• Analysis of preparation methods, administration routes, and pharmaceutical forms.
• Discussion of ocular distribution and targeting strategies for posterior segment delivery.

Main Results:

• Lipid nanoparticles demonstrate significant potential as drug carriers for posterior eye pathologies.
• Various lipid nanoparticle formulations offer tailored delivery solutions.
• Targeting strategies enhance drug accumulation in the posterior ocular segment.

Conclusions:

• Lipid nanoparticles are promising for advanced ocular drug delivery systems.
• Further research into lipid nanoparticle formulations can optimize treatment for posterior eye diseases.
• Targeted delivery systems are crucial for improving therapeutic efficacy.